168 related articles for article (PubMed ID: 36387097)
1. Development of D-α-Tocopherol polyethylene glycol 1000 succinate fabricated nanostructural lipid carrier of sorafenib tosylate for metastatic colorectal targeting application: Stability, physical characterization, cytotoxicity, and apoptotic studies against SW48 cells PTEN.
Bhattacharya S; Sharma S; Prajapati BG
Front Oncol; 2022; 12():990841. PubMed ID: 36387097
[TBL] [Abstract][Full Text] [Related]
2. Engineered Nanoscale Lipid-Based Formulation as Potential Enhancer of Gefitinib Lymphatic Delivery: Cytotoxicity and Apoptotic Studies Against the A549 Cell Line.
Sherif AY; Harisa GI; Alanazi FK; Nasr FA; Alqahtani AS
AAPS PharmSciTech; 2022 Jul; 23(6):183. PubMed ID: 35773422
[TBL] [Abstract][Full Text] [Related]
3. Topical anesthesia therapy using lidocaine-loaded nanostructured lipid carriers: tocopheryl polyethylene glycol 1000 succinate-modified transdermal delivery system.
Zhao X; Sun Y; Li Z
Drug Des Devel Ther; 2018; 12():4231-4240. PubMed ID: 30587919
[TBL] [Abstract][Full Text] [Related]
4. Integrating the drug, disulfiram into the vitamin E-TPGS-modified PEGylated nanostructured lipid carriers to synergize its repurposing for anti-cancer therapy of solid tumors.
Banerjee P; Geng T; Mahanty A; Li T; Zong L; Wang B
Int J Pharm; 2019 Feb; 557():374-389. PubMed ID: 30610896
[TBL] [Abstract][Full Text] [Related]
5. TPGS decorated NLC shift gefitinib from portal absorption into lymphatic delivery: Intracellular trafficking, biodistribution and bioavailability studies.
Harisa GI; Sherif AY; Alanazi FK; Ali EA; Omran GA; Nasr FA; Attia SM; Alqahtani AS
Colloids Surf B Biointerfaces; 2023 Mar; 223():113148. PubMed ID: 36706479
[TBL] [Abstract][Full Text] [Related]
6. Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers.
Thatipamula R; Palem C; Gannu R; Mudragada S; Yamsani M
Daru; 2011; 19(1):23-32. PubMed ID: 22615636
[TBL] [Abstract][Full Text] [Related]
7. D-α-tocopherol polyethylene glycol succinate-based derivative nanoparticles as a novel carrier for paclitaxel delivery.
Wu Y; Chu Q; Tan S; Zhuang X; Bao Y; Wu T; Zhang Z
Int J Nanomedicine; 2015; 10():5219-35. PubMed ID: 26316751
[TBL] [Abstract][Full Text] [Related]
8. Formulation and evaluation of lidocaine lipid nanosystems for dermal delivery.
Pathak P; Nagarsenker M
AAPS PharmSciTech; 2009; 10(3):985-92. PubMed ID: 19641997
[TBL] [Abstract][Full Text] [Related]
9. Antitumor efficiency of D-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-lactide) nanoparticle-based delivery of docetaxel in mice bearing cervical cancer.
Wang Z; Zeng X; Ma Y; Liu J; Tang X; Gao Y; Liu K; Zhang J; Ming P; Huang L; Mei L
J Biomed Nanotechnol; 2014 Aug; 10(8):1509-19. PubMed ID: 25016651
[TBL] [Abstract][Full Text] [Related]
10. Development of α-Tocopherol Succinate-Based Nanostructured Lipid Carriers for Delivery of Paclitaxel.
Marathe S; Shadambikar G; Mehraj T; Sulochana SP; Dudhipala N; Majumdar S
Pharmaceutics; 2022 May; 14(5):. PubMed ID: 35631620
[TBL] [Abstract][Full Text] [Related]
11. Improvising anti-leishmanial activity of amphotericin B and paromomycin using co-delivery in d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS) tailored nano-lipid carrier system.
Parvez S; Yadagiri G; Singh A; Karole A; Singh OP; Sundar S; Mudavath SL
Chem Phys Lipids; 2020 Sep; 231():104946. PubMed ID: 32621810
[TBL] [Abstract][Full Text] [Related]
12. D-α-tocopherol polyethylene glycol 1000 succinate-modified liposomes with an siRNA corona confer enhanced cellular uptake and targeted delivery of doxorubicin via tumor priming.
Tan X; Fang Y; Ren Y; Li Y; Wu P; Yang X; Liu W
Int J Nanomedicine; 2019; 14():1255-1268. PubMed ID: 30863058
[TBL] [Abstract][Full Text] [Related]
13. Tamoxifen-loaded nanostructured lipid carrier as a drug delivery system: characterization, stability assessment and cytotoxicity.
How CW; Rasedee A; Manickam S; Rosli R
Colloids Surf B Biointerfaces; 2013 Dec; 112():393-9. PubMed ID: 24036474
[TBL] [Abstract][Full Text] [Related]
14. Primaquine Loaded Solid Lipid Nanoparticles (SLN), Nanostructured Lipid Carriers (NLC), and Nanoemulsion (NE): Effect of Lipid Matrix and Surfactant on Drug Entrapment, in vitro Release, and ex vivo Hemolysis.
Wu KW; Sweeney C; Dudhipala N; Lakhani P; Chaurasiya ND; Tekwani BL; Majumdar S
AAPS PharmSciTech; 2021 Sep; 22(7):240. PubMed ID: 34590195
[TBL] [Abstract][Full Text] [Related]
15. Topical nanostructured lipid carrier gel of quercetin and resveratrol: Formulation, optimization, in vitro and ex vivo study for the treatment of skin cancer.
Imran M; Iqubal MK; Imtiyaz K; Saleem S; Mittal S; Rizvi MMA; Ali J; Baboota S
Int J Pharm; 2020 Sep; 587():119705. PubMed ID: 32738456
[TBL] [Abstract][Full Text] [Related]
16. Resveratrol-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications.
Gokce EH; Korkmaz E; Dellera E; Sandri G; Bonferoni MC; Ozer O
Int J Nanomedicine; 2012; 7():1841-50. PubMed ID: 22605933
[TBL] [Abstract][Full Text] [Related]
17. Lipid- and TPGS-Based Core-Shell-Type Nanocapsules Endowed with High Paclitaxel Loading and Enhanced Anticancer Potential.
Katiyar SS; Patil R; Ghadi R; Kuche K; Kushwah V; Dora CP; Jain S
AAPS PharmSciTech; 2022 Aug; 23(7):238. PubMed ID: 36002600
[TBL] [Abstract][Full Text] [Related]
18. Co-delivery of Doxorubicin and D-α-Tocopherol Polyethylene Glycol 1000 Succinate by Magnetic Nanoparticles.
Metin E; Mutlu P; Gündüz U
Anticancer Agents Med Chem; 2018; 18(8):1138-1147. PubMed ID: 29532763
[TBL] [Abstract][Full Text] [Related]
19. Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells.
Li N; Fu T; Fei W; Han T; Gu X; Hou Y; Liu Y; Yang J
J Pharm Pharmacol; 2019 Aug; 71(8):1243-1254. PubMed ID: 31215039
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid nanoparticles co-loaded with doxorubicin and α-tocopherol succinate are effective against drug-resistant cancer cells in monolayer and 3-D spheroid cancer cell models.
Oliveira MS; Aryasomayajula B; Pattni B; Mussi SV; Ferreira LAM; Torchilin VP
Int J Pharm; 2016 Oct; 512(1):292-300. PubMed ID: 27568499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
